OPRL1 antibody (C-Term)
-
- Target See all OPRL1 Antibodies
- OPRL1 (Opiate Receptor-Like 1 (OPRL1))
-
Binding Specificity
- C-Term
-
Reactivity
- Human, Mouse, Rat
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This OPRL1 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)
- Specificity
- OPRL1 Antibody detects endogenous levels of total OPRL1.
- Predicted Reactivity
- Pig,Horse,Sheep,Dog
- Purification
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human OPRL1, corresponding to a region within C-terminal amino acids.
- Isotype
- IgG
- Top Product
- Discover our top product OPRL1 Primary Antibody
-
-
- Application Notes
- WB 1:500-1:2000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- OPRL1 (Opiate Receptor-Like 1 (OPRL1))
- Alternative Name
- OPRL1 (OPRL1 Products)
- Synonyms
- KOR-3 antibody, NOCIR antibody, OOR antibody, ORL1 antibody, KOR3 antibody, LC132 antibody, MOR-C antibody, OFQR antibody, Oprl antibody, XOR1 antibody, OPRL antibody, ORGC antibody, morc antibody, opioid related nociceptin receptor 1 antibody, opiate receptor-like 1 L homeolog antibody, opiate receptor-like 1 antibody, opioid receptor-like 1 antibody, OPRL1 antibody, oprl1.L antibody, LOC100335303 antibody, Oprl1 antibody
- Background
-
Description: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.
Gene: OPRL1
- Molecular Weight
- 41 kDa,
- Gene ID
- 4987
- UniProt
- P41146
-